| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA934: Foslevodopa–foscarbidopa for treating advanced Parkinson's with motor symptoms |
|
Medicine details |
|
| Medicine name | foslevodopa-foscarbidopa (Produodopa®) |
| Formulation | subcutaneous infusion |
| Reference number | 4661 |
| Indication | Treating Parkinson's disease with motor symptoms |
| Company | AbbVie Ltd |
| BNF chapter | Central nervous system |
| Submission type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 20/10/2023 |
| NICE guidance | TA934: Foslevodopa–foscarbidopa for treating advanced Parkinson's with motor symptoms |